Mayo Clinic Platform launches multiyear pathway for 12 AI startups

Mayo Clinic Platform has launched a multiyear pathway program within its Accelerate initiative, selecting an inaugural cohort of 12 healthcare technology companies. The program is designed to support mature and clinical-stage artificial intelligence companies by providing sustained access to a secure discovery environment, technical mentorship, and de-identified longitudinal clinical datasets.

The participating companies are developing AI-powered solutions to enhance care delivery and enterprise operations. The cohort includes Cappsule, which focuses on ambient clinical monitoring; CerebraAI, which aims to upgrade CT scan diagnostic accuracy; Clair Health, a women’s health platform; Durotimi AI, focused on precision oncology; Electrokare, building biological intelligence infrastructure; Floe Health, a clinical reasoning engine; Koroid, an AI-native operating system for healthcare operations; MedLink Global, providing psychiatric care tools; OPTT Health, a digital mental healthcare platform; PONS, an ultrasound diagnostic intelligence tool; Radical Health, a patient-facing second-opinion service; and Respiree, which utilizes machine learning for clinical validation.